First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition
Scientists and clinicians at St. Jude Children’s Research Hospital identified the genetic vulnerability BARD1 in a patient with pediatric...
Aug 30, 2024
Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma
The study marks the first time that researchers identified malignant cells responsible for relapse in neuroblastoma and offers insights...
Aug 29, 2024
New research from Children’s Hospital of Philadelphia and St. Jude poised to transform approach to diagnosing and treating acute leukemia in children
Researchers at Children’s Hospital of Philadelphia (CHOP), St. Jude Children’s Research Hospital (St. Jude) and the Children’s Oncology...
Aug 27, 2024
Researchers enhance natural killer cells to target pediatric brain cancer
In work published in Bioactive Materials , a research team led by Department of Chemistry and Biochemistry Professor Qing-Xiang "Amy"...
Aug 23, 2024
Scientists identify genes linked to relapse in the most common form of childhood leukemia
Researchers identified genetic predictors of relapse in standard risk B-cell acute lymphoblastic leukemia highlighting the role of...
Aug 21, 2024
Air pollution linked to worse childhood cancer survival
Exposure to air pollution is associated with worse overall survival (OS) among children with cancer, shows a large US study. Read more:...
Aug 20, 2024
Discovery of Key Genetic Driver in Neuroblastoma Paves Way to New Therapeutic Approaches
Led by the Children’s Cancer Institute , a multi-institutional study published in Nature Communications has shown for the first time...
Aug 19, 2024
UCLA launches groundbreaking clinical trial for vaccine targeting aggressive pediatric brain cancer
In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive...
Aug 16, 2024
Improved chemokine homing enhances CAR T-cell therapy for osteosarcoma
Scientists at St. Jude Children’s Research Hospital identified chemokines expressed by osteosarcoma that improved CAR T-cell homing, with...
Aug 14, 2024
Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma
A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma...
Aug 13, 2024